Stacy Markel - 28 Feb 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
CHIEF PEOPLE OFFICER
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
28 Feb 2025
Net transactions value
$0
Form type
4
Filing time
04 Mar 2025, 18:35:24 UTC
Previous filing
04 Mar 2024
Next filing
18 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NUVB Class A Common Stock 16,591 28 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +500,000 $0.000000 500,000 28 Feb 2025 Class A Common Stock 500,000 $1.97 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,000 shares acquired on May 17, 2024 and 3,000 shares acquired on November 19, 2024 under the Issuer's 2021 Employee Stock Purchase Plan.
F2 Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.